# scDrugLink: Single-Cell Drug Repurposing for CNS Diseases via Computationally Linking Drug Targets and Perturbation Signatures
scDrugLink integrates a single-cell RNA-seq disease atlas with drug targets and perturbation signatures to improve repurposing outcomes both at the cell-type level and the whole-atlas level.

![scDrugLink pipeline](scDrugLink_pipeline.jpg)
